Article
Lynch syndrome: further defining the pediatric spectrum.
Cancer genetics - 1 Nov 2021
Self Chelsea, Suttman Alexandra, Wolfe Schneider Kami, Hoffman Lindsey
Abstract excerpt
Lynch syndrome (LS) is an autosomal dominant cancer predisposition syndrome defined molecularly by the presence of a pathogenic heterozygous variant in one of the mismatch repair genes: MLH1, MSH2, MSH6, PMS2, or EPCAM. The incidence of LS in the general population is estimated at 1 in 279, with an even higher incidence in those with colorectal cancer and endometrial cancer, the two most common Lynch-associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
